PRESS RELEASE: In Aging’s latest cover paper, researchers conducted a new study to elucidate the potential role of HDAC4 in the regulation of cellular senescence and skin aging.
Aging (Aging-US) Authors
Dennis Mangan and Dr. Mikhail Blagosklonny discuss how Dr. Blagosklonny’s cancer research led him to the study of aging, whether rapamycin is the most important anti-aging intervention currently available, his skepticism about metformin as an anti-aging drug, and more.
PRESS RELEASE: Impact Journals is sponsoring Team Open Access on June 25, 2022, in the annual cycling event to end cancer: The Ride for Roswell.
PRESS RELEASE: In Aging’s latest cover paper, researchers discovered that protein levels of Humanin G are significantly lower in patients with age-related macular degeneration.
PRESS RELEASE: Aging is sponsoring the Systems Aging Gordon Research Conference, “Systemic Processes, Omics Approaches and Biomarkers in Aging,” from May 29 to June 3, 2022.
PRESS RELEASE: Dr. Mikhail Blagosklonny published a new review paper in Aging (Aging-US), entitled, “Hallmarks of cancer and hallmarks of aging.”
PRESS RELEASE: Mikhail Blagosklonny, M.D., Ph.D., published a new research perspective about upcoming research at Altos Labs.
Aging recently compiled a new Special Collection of research publications co-authored by renowned researcher Dr. Steve Horvath.
Dr. David Sinclair from Harvard Medical School and member of the Aging Editorial Board details his review published by Aging on May 29, 2020, entitled, “Why does COVID-19 disproportionately affect older people?“
Dr. Judith Campisi discusses her priority research paper published in 2021 by Aging, entitled, “Cdkn1a transcript variant 2 is a marker of aging and cellular senescence.”